These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7955453)

  • 1. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.
    Franklyn J; Betteridge J; Holder R; Daykin J; Lilley J; Sheppard M
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):425-32. PubMed ID: 7955453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of estrogen replacement therapy upon bone mineral density in thyroxine-treated postmenopausal women with a past history of thyrotoxicosis.
    Franklyn JA; Betteridge J; Holder R; Sheppard MC
    Thyroid; 1995 Oct; 5(5):359-63. PubMed ID: 8563472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of replacement doses of thyroxine on bone mineral density.
    Hanna FW; Pettit RJ; Ammari F; Evans WD; Sandeman D; Lazarus JH
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):229-34. PubMed ID: 9579237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Astazi P; Caradonna P
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):529-35. PubMed ID: 9425392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
    Ongphiphadhanakul B; Puavilai G; Rajatanavin R
    J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women.
    Kung AW; Lorentz T; Tam SC
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):535-40. PubMed ID: 8252741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
    J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term thyroxine on bone mineral density and serum cholesterol.
    Fowler PB; McIvor J; Sykes L; Macrae KD
    J R Coll Physicians Lond; 1996; 30(6):527-32. PubMed ID: 8961207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone mineral density in patients on long-term therapy with levothyroxine].
    Korsić M; Cvijetić S; Dekanić-Ozegović D; Bolanća S; Kozić B
    Lijec Vjesn; 1998 May; 120(5):103-5. PubMed ID: 9748785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of levothyroxine replacement therapy on bone and mineral metabolism in patients with hypothyroidism].
    Chai R; Ye Z; Zhan Z; Liu W; Yu M; Liu Y
    Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):18-21. PubMed ID: 11798620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy.
    Garton M; Reid I; Loveridge N; Robins S; Murchison L; Beckett G; Reid D
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):747-55. PubMed ID: 7889610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global skeletal uptake of technetium-99m methylene diphosphonate in female patients receiving suppressive doses of L-thyroxine for differentiated thyroid cancer.
    Frusciante V; Carnevale V; Scillitani A; Zingrillo M; Dicembrino F; Giannatempo GM; Ghiggi MR; Minisola S
    Eur J Nucl Med; 1998 Feb; 25(2):139-43. PubMed ID: 9473261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation.
    Gyulai L; Bauer M; Garcia-Espana F; Hierholzer J; Baumgartner A; Berghöfer A; Whybrow PC
    J Affect Disord; 2001 Oct; 66(2-3):185-91. PubMed ID: 11578671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy.
    Mazokopakis EE; Starakis IK; Papadomanolaki MG; Batistakis AG; Papadakis JA
    Curr Med Res Opin; 2006 Jul; 22(7):1369-73. PubMed ID: 16834835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma.
    Diamond T; Nery L; Hales I
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1184-8. PubMed ID: 2026740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
    Rahim A; Holmes SJ; Adams JE; Shalet SM
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mass after long-term euthyroidism in former hyperthyroid women treated with (131)I influence of menopausal status.
    Serraclara A; Jódar E; Sarabia F; Hawkins F
    J Clin Densitom; 2001; 4(3):249-55. PubMed ID: 11740067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interfemur variation of bone mineral density in patients receiving high-dose thyroxin therapy.
    Goerres G; Theiler R; Müller-Brand J
    Calcif Tissue Int; 1998 Aug; 63(2):98-101. PubMed ID: 9685511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass.
    Jódar E; Begoña López M; García L; Rigopoulou D; Martínez G; Hawkins F
    Osteoporos Int; 1998; 8(4):311-6. PubMed ID: 10024900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.